Moleculin Biotech, Inc. (MBRX)
0.4856
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.4856
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Price to Book Value : 0.2976 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.2983 |
| October 01, 2026 | 0.3087 |
| September 30, 2026 | 0.3066 |
| September 29, 2026 | 0.3226 |
| September 28, 2026 | 0.3487 |
| September 25, 2026 | 0.3686 |
| September 24, 2026 | 0.3474 |
| September 23, 2026 | 0.3235 |
| September 22, 2026 | 0.3462 |
| September 21, 2026 | 0.3188 |
| September 18, 2026 | 0.4737 |
| September 17, 2026 | 0.4779 |
| September 16, 2026 | 0.4534 |
| September 15, 2026 | 0.4605 |
| September 14, 2026 | 0.475 |
| September 11, 2026 | 0.4381 |
| September 10, 2026 | 0.5085 |
| September 09, 2026 | 0.4688 |
| September 08, 2026 | 0.4596 |
| September 04, 2026 | 0.435 |
| September 03, 2026 | 0.4139 |
| September 02, 2026 | 0.4253 |
| September 01, 2026 | 0.3983 |
| August 31, 2026 | 0.395 |
| August 28, 2026 | 0.3982 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.422 |
| August 26, 2026 | 0.3677 |
| August 25, 2026 | 0.3744 |
| August 24, 2026 | 0.3734 |
| August 21, 2026 | 0.3634 |
| August 20, 2026 | 0.3619 |
| August 19, 2026 | 0.3505 |
| August 18, 2026 | 0.3738 |
| August 17, 2026 | 0.3719 |
| August 14, 2026 | 0.3751 |
| August 13, 2026 | 0.3501 |
| August 12, 2026 | 0.32 |
| August 11, 2026 | 0.2727 |
| August 10, 2026 | 0.2637 |
| August 07, 2026 | 0.2509 |
| August 06, 2026 | 0.2359 |
| August 05, 2026 | 0.239 |
| August 04, 2026 | 0.2509 |
| August 03, 2026 | 0.2604 |
| July 31, 2026 | 0.2451 |
| July 30, 2026 | 0.625 |
| July 29, 2026 | 0.8333 |
| July 28, 2026 | 1.342 |
| July 27, 2026 | 1.342 |
| July 24, 2026 | 1.299 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.648 |
| Alnylam Pharmaceuticals, Inc. | 21.72 |
| Savara, Inc. | 6.841 |
| Vericel Corp. | 5.685 |
| Biogen, Inc. | 1.751 |
Price to Book Value Related Metrics
| Price | 0.4856 |
| Earnings Yield | -3.53K% |
| Market Cap | 3.448M |